BRPI0811538A2 - Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares. - Google Patents

Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.

Info

Publication number
BRPI0811538A2
BRPI0811538A2 BRPI0811538-9A BRPI0811538A BRPI0811538A2 BR PI0811538 A2 BRPI0811538 A2 BR PI0811538A2 BR PI0811538 A BRPI0811538 A BR PI0811538A BR PI0811538 A2 BRPI0811538 A2 BR PI0811538A2
Authority
BR
Brazil
Prior art keywords
cyclosporins
patients
treatment
intraocular lenses
intraocular
Prior art date
Application number
BRPI0811538-9A
Other languages
English (en)
Inventor
Eric D Donnenfeld
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0811538A2 publication Critical patent/BRPI0811538A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/16—Intraocular lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0811538-9A 2007-05-04 2008-05-02 Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares. BRPI0811538A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91595007P 2007-05-04 2007-05-04
PCT/US2008/062325 WO2008137617A1 (en) 2007-05-04 2008-05-02 Use of cyclosporines in the treatment of patients with intraocular lenses

Publications (1)

Publication Number Publication Date
BRPI0811538A2 true BRPI0811538A2 (pt) 2015-08-11

Family

ID=39523525

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811538-9A BRPI0811538A2 (pt) 2007-05-04 2008-05-02 Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.

Country Status (9)

Country Link
US (1) US20100144609A1 (pt)
EP (1) EP2152291B1 (pt)
JP (1) JP2010525929A (pt)
CN (1) CN101687013A (pt)
AU (1) AU2008247680A1 (pt)
BR (1) BRPI0811538A2 (pt)
CA (1) CA2686234A1 (pt)
RU (1) RU2009144186A (pt)
WO (1) WO2008137617A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009339A1 (en) * 2009-04-14 2011-01-13 Allergan, Inc Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
US9573978B2 (en) * 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
KR101242658B1 (ko) 2010-10-11 2013-03-19 한국과학기술연구원 고굴절 친수성 안내 렌즈 및 그 제조방법
JP5805774B2 (ja) * 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンアナログ
CA2814191A1 (en) * 2010-10-12 2012-04-19 Allergan, Inc. Cyclosporin analogs
MY180581A (en) * 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JP2015519368A (ja) 2012-06-01 2015-07-09 アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンａ類似体
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
JP2024521968A (ja) * 2021-06-14 2024-06-04 サン ファーマシューティカル インダストリーズ リミテッド 白内障手術を受ける患者において使用するための、シクロスポリン製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
KR920003601B1 (ko) * 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
WO2006014738A2 (en) 2004-07-22 2006-02-09 Cornell Research Foundation, Inc. Accommodating intraocular lens and methods of use
EP1904056B1 (en) * 2005-07-18 2009-04-29 Minu, L.L.C. Use of a macrolide to restore corneal sensation

Also Published As

Publication number Publication date
CA2686234A1 (en) 2008-11-13
JP2010525929A (ja) 2010-07-29
EP2152291A1 (en) 2010-02-17
EP2152291B1 (en) 2012-10-24
AU2008247680A1 (en) 2008-11-13
US20100144609A1 (en) 2010-06-10
RU2009144186A (ru) 2011-06-10
CN101687013A (zh) 2010-03-31
WO2008137617A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
BRPI0811538A2 (pt) Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.
BRPI0719345A2 (pt) Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
SI1827441T1 (sl) Kombinacije za zdravljenje bolezni, povezanih s celično proliferacijo
BRPI0814102A2 (pt) Implante pélvico, e, kit.
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
ATE523175T1 (de) Ophthalmischer injektor
CL2012001178A1 (es) 2-[(4s)-6-(4-cloro-fenil)-1-metil-8-(metiloxi)-4h-[1,2,4]-triazolo-[4,3-a][1,4]-benzo-diazepin-4-il]-n-etil-acetamida o una sal; composicion y combinacion farmaceutica; y uso en el tratamiento de enfermedades autoinmunes y/o inflamatorias cronicas y cancer.
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
BRPI0813318A2 (pt) implante pélvico, e, kit
BR112012004154A2 (pt) "derivados de oxazina e seu uso no tratamento de distúrbios neurológicos"
EP2506921A4 (en) IMPLANTABLE CUBE SILICON CARBIDE NEURAL PROTECTION
FR2913196B1 (fr) Implant oculaire accomodatif
DE602005002413D1 (de) Wegwerfhöschen
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
BRPI0806696A2 (pt) Visão intermediária aperfeiçoada com óptica multifocal fácica utilizando acomodação residual.
BRPI0916170A2 (pt) "artigo absorvente com característica de alívio de cintura"
EP1912650B8 (en) Use of flibanserin in the treatment of obesity
PL2148667T3 (pl) Stosowanie pochodnych cycloheksanoheksolu w leczeniu chorób oczu
BRPI0810647A2 (pt) " uso de trans carotenóides bipolares como um pré-tratamento e no tratamento de doença vascular periférica ".
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
BRPI0909096A2 (pt) uso de conjugados de interleicna-1 no tratamento de diabetes

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.